Abstract
Facet joint osteoarthritis (facet syndrome) has been suggested to be one of the key pain generators in degenerative spinal conditions. Treatment options for facet syndrome include physical therapy, intra-articular injections, radiofrequency ablation, and surgery. Tissue engineering offers promise for the treatment of various musculoskeletal system disorders. Mesenchymal stem cells (MSCs) have multipotent characteristics and can differentiate into various tissues including articular cartilage. In this article, we analyze the literature and emphasize potential advantages and future perspectives in the treatment of articular facet joint cartilage defects using MSCs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
